Louisiana State University Health New Orleans, an NCI-NCORPS designated institution, and ConcertAI, LLC have formed a five-year partnership to improve the diversity of clinical trials and ensure broader clinical trial access throughout the Gulf South region.
Researchers at University of California San Diego School of Medicine have been selected to lead components of the NIH Common Fund’s Bridge to Artificial Intelligence program.
Indivumed GmbH and CELLphenomics GmbH have formed a partnership to create a unique platform for faster and more efficient discovery and validation of therapeutic targets.Â
C2i Genomics and Karkinos Healthcare have partnered to co-develop the minimal residual disease market in India.Â
Case Western Reserve University signed an exclusive license agreement with Picture Health to develop AI technologies to help predict, diagnose, and treat lung cancer.Â
Researchers from the Gwangju Institute of Science and Technology have developed a deep learning model that predicts unexpected drug-drug interactions (DDIs) based on their effects on gene expression.Â
